Correlation Between Aerovate Therapeutics and Absci Corp
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Absci Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Absci Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Absci Corp, you can compare the effects of market volatilities on Aerovate Therapeutics and Absci Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Absci Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Absci Corp.
Diversification Opportunities for Aerovate Therapeutics and Absci Corp
-0.52 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Aerovate and Absci is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Absci Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Absci Corp and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Absci Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Absci Corp has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Absci Corp go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and Absci Corp
Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 0.61 times more return on investment than Absci Corp. However, Aerovate Therapeutics is 1.64 times less risky than Absci Corp. It trades about 0.11 of its potential returns per unit of risk. Absci Corp is currently generating about -0.15 per unit of risk. If you would invest 245.00 in Aerovate Therapeutics on September 1, 2024 and sell it today you would earn a total of 18.00 from holding Aerovate Therapeutics or generate 7.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Aerovate Therapeutics vs. Absci Corp
Performance |
| Timeline |
| Aerovate Therapeutics |
| Absci Corp |
Aerovate Therapeutics and Absci Corp Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aerovate Therapeutics and Absci Corp
The main advantage of trading using opposite Aerovate Therapeutics and Absci Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Absci Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Absci Corp will offset losses from the drop in Absci Corp's long position.| Aerovate Therapeutics vs. Tff Pharmaceuticals | Aerovate Therapeutics vs. Eliem Therapeutics | Aerovate Therapeutics vs. Inhibrx | Aerovate Therapeutics vs. Enliven Therapeutics |
| Absci Corp vs. Recursion Pharmaceuticals | Absci Corp vs. Affimed NV | Absci Corp vs. Sana Biotechnology | Absci Corp vs. Relay Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |